EnsoData, Inc.

EnsoData is a healthcare technology company specializing in AI-powered software solutions for sleep medicine diagnostics and management. Founded in 2015 and based in Madison, Wisconsin, the company develops FDA-cleared cloud-based platforms that automate sleep study scoring and analysis using machine learning to process polysomnography (PSG) and home sleep apnea test (HSAT) waveforms. EnsoData's integrated ecosystem—comprising EnsoHST (multi-night home sleep testing device), EnsoSleep (AI-assisted scoring and analysis), EnsoHub (centralized study management platform), and Therapy Track (long-term therapy monitoring)—enables sleep clinics to streamline workflows, reduce diagnostic turnaround times, and improve clinical accuracy. The platform has processed over 2.8 million studies and impacted more than 2.5 million patients. EnsoData serves 500+ sleep clinics globally and achieves 97% patient success rates with >92% sensitivity for obstructive sleep apnea detection. The company's solutions address scalability challenges in sleep medicine and expand access to diagnosis for the estimated 425 million patients worldwide with undiagnosed sleep disorders.